文献速递乳腺外科围术期管理与 ERAS

微创腋窝淋巴结清扫与传统腋窝淋巴结清扫短期疗效比较

Minimally invasive axillary lymph node dissection versus conventional axillary lymph node dissection: a comparative study on short-term efficacy in breast cancer.
PubMed 文献 · Surg Endosc · 2025-06-25

该回顾性研究纳入147例腋窝淋巴结阳性乳腺癌患者,比较微创腋窝淋巴结清扫(MIAD,71例)与传统清扫(CAD,76例)的短期疗效。MIAD组术中出血量更少(5.63±4.16 vs 21.13±6.81 ml,p<0.001),术后疼痛更轻、肩关节活动度更好、生活质量评分更高(112.90±10.80 vs 106.88±11.11,p=0.001),但手术时间延长9.39 min(47.52±8.95 vs 39.09±9.20 min,p<0.001);两组并发症和初期肿瘤学结局无显著差异。

要点

  • MIAD术中出血量显著少于CAD(5.63±4.16 vs 21.13±6.81 ml,p<0.001)。
  • MIAD术后疼痛更轻、肩关节活动度更好、生活质量评分更高(p=0.001)。
  • MIAD手术时间平均延长9.39 min,但BMI≥24 kg/m²患者两组手术时间无统计学差异。

核心结论

  • MIAD是CAD的安全替代方案,尤其适用于肥胖患者,可减少术中出血并改善术后肩关节功能和生活质量。

研究设计与样本

  • 回顾性分析2022年1月至2024年8月乳腺外科收治的147例腋窝淋巴结阳性乳腺癌患者,其中MIAD组71例(内镜辅助25例、机器人辅助46例),CAD组76例。

主要发现

  • MIAD组术中出血量低于CAD组(5.63±4.16 vs 21.13±6.81 ml,p<0.001)。
  • MIAD组手术时间较CAD组延长9.39 min(47.52±8.95 vs 39.09±9.20 min,p<0.001),但BMI≥24 kg/m²患者两组手术时间无统计学差异。
  • MIAD组术后疼痛程度更低、肩关节活动度更好、DSAH和FACT-B+4评分更高(112.90±10.80 vs 106.88±11.11,p=0.001)。
  • 两组术后并发症和初期肿瘤学结局无统计学显著差异。

临床怎么用

  • 对于腋窝淋巴结阳性的乳腺癌患者,MIAD可作为CAD的替代选择,尤其适合BMI≥24 kg/m²的肥胖患者。
  • MIAD虽延长手术时间,但可减少出血、减轻疼痛并改善术后肩关节功能和生活质量。

局限性

  • 本研究为单中心回顾性分析,样本量有限,随访时间较短,未报告长期肿瘤学结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study aims to compare the short-term clinical efficacy of minimally invasive axillary lymph node dissection (MIAD) versus conventional axillary lymph node dissection (CAD) in the treatment of breast cancer with positive axillary lymph nodes. METHODS: We performed a retrospective analysis of the clinical data of breast cancer patients who underwent MIAD and CAD in the Breast Surgery Department from January 2022 to August 2024. The primary outcomes assessed included surgical results, complications, post-operative upper limb function, and quality of life score for both groups. RESULTS: This study enrolled 147 patients, with 71 undergoing MIAD (including 25 with endoscopic-assisted axillary lymph node dissection and 46 with robotic-assisted axillary lymph node dissection) and 76 undergoing CAD. Compared to CAD, the mean intraoperative blood loss in the MIAD was lower (5.63 ± 4.16 vs. 21.13 ± 6.81 ml, p < 0.001). Impressively, in patients with BMI ≥ 24 kg/m2, there was no statistical difference in operative time between the two groups. Furthermore, despite an overall increase of 9.39 min in surgical duration in MIAD (47.52 ± 8.95 vs. 39.09 ± 9.20 min, p < 0.001), its advantages include lower degree of post-operative pain, better post-operative shoulder joint range of motion, and DSAH and FACT-B + 4 score (112.90 ± 10.80 vs. 106.88 ± 11.11, p = 0.001). There was no statistically significant difference in the post-operative complications and initial oncological outcomes between the two groups. CONCLUSIONS: MIAD is a safe alternative to CAD, particularly for obese patients. It significantly reduces intraoperative blood loss while improving post-operative shoulder joint function and enhancing quality of life.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Li Z, Chen Z, Wei L, et al. Minimally invasive axillary lymph node dissection versus conventional axillary lymph node dissection: a comparative study on short-term efficacy in breast cancer. Surg Endosc. 2025. PMID: 40562955. doi:10.1007/s00464-025-11863-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。